Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Diabetes|September 1, 1988
Reevaluation of urine C-peptide as measure of insulin secretionH Tillil, E T Shapiro, B D Given, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1986
Ingestion of a mixed meal does not affect the metabolic clearance rate of biosynthetic human C-peptideJ Licinio-Paixao, K S Polonsky, B D Given, et al.
The Journal of Clinical Investigation|January 1, 1986
Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patientsK S Polonsky, J Licinio-Paixao, B D Given, et al.
The American Journal of Cardiology|June 5, 1989
Antihypertensive effect of dilevalol is directly related to dose and plasma concentrationsB D Given, G Perentesis, J D Christopher, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1989
Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitusE T Shapiro, E Van Cauter, H Tillil, et al.
The Journal of Clinical Investigation|February 1, 1986
Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulinK Nanjo, T Sanke, M Miyano, et al.
Clinical Pharmacology and Therapeutics|December 1, 1989
Pharmacokinetics and pharmacodynamics of dilevalolD M Tenero, M B Bottorff, B D Given, et al.
Diabetologia|February 1, 1987
Insulin Wakayama: familial mutant insulin syndrome in JapanK Nanjo, M Miyano, M Kondo, et al.
The New England Journal of Medicine|January 17, 1980
Diabetes due to secretion of an abnormal insulinB D Given, M E Mako, H S Tager, et al.
The New England Journal of Medicine|May 12, 1988
Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitusK S Polonsky, B D Given, L J Hirsch, et al.
Pageof 3